期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 51, 期 5, 页码 1835-1836出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01534-06
关键词
-
资金
- NIAID NIH HHS [N01 AI00042] Funding Source: Medline
- Wellcome Trust [077166/Z/05/Z] Funding Source: Medline
Ex vivo conversion of the anti-influenza drug oseltamivir to its active metabolite can be inhibited by the esterase inhibitor dichlorvos or by using commercial fluoride-oxalate tubes. Oseltamivir and its active metabolite remain intact in plasma samples during a proposed virus heat inactivation step: incubation at 60 degrees C for 45 min.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据